Top Markets
Coin of the day
LifeMD, Inc. LifeMD, Inc.

LifeMD, Inc.

LFMDP
Classifica tra le azioni #6273
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects... LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Prezzo delle azioni
$23.31
Capitalizzazione di mercato
$1.05B
Variazione (1 giorno)
-0.81%
Variazione (1 anno)
-6.37%
Paese
US
Scambia LifeMD, Inc. (LFMDP)

Categoria

Rapporto P/E per LifeMD, Inc. (LFMDP)
Rapporto P/E al March 2026 TTM: 12.04
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di LifeMD, Inc., il rapporto P/E attuale (TTM) è 12.04. Alla fine del 2023, il rapporto P/E era -13.65.
Storico del rapporto P/E per LifeMD, Inc. da 2011 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 12.04 -211.44%
2024 -10.80 -20.86%
2023 -13.65 922.40%
2022 -1.33 -21.69%
2021 -1.70 10.66%
2020 -1.54 -8.50%
2019 -1.68 -66.24%
2018 -4.99 -59.79%
2017 -12.40 49.85%
2016 -8.27 -86.13%
2015 -59.64 804.23%
2014 -6.60 -76.83%
2013 -28.47 188.12%
2012 -9.88 -33.88%
2011 -14.95 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
30.93 156.99%
HK
31.77 163.96%
BR
17.49 45.30%
JP
18.15 50.80%
CN
14.54 20.82%
JP
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.